
Cancer Marker Profile - Female near me in Koderma









The Cancer Marker Profile - Female is a comprehensive female cancer marker package designed to support risk assessment, diagnosis support, and long-term monitoring of selected malignancies. It measures multiple tumor markers and hematological parameters that may indicate the presence of malignancy, disease progression, or response to treatment. This panel is widely available with Tata 1mg labs at an affordable price in Koderma.








What does Cancer Marker Profile - Female measure?
Contains 29 testsThe Cancer Marker Profile - Female measures levels of several tumor markers and hematological parameters like CBC (Complete Blood Count) and ESR (Erythrocyte Sedimentation Rate) in the blood. The tumor markers include:
Alpha Feto Protein (AFP), Tumour Marker: It is associated with liver cancer and certain germ cell tumors, but levels may also increase in chronic liver diseases such as hepatitis or cirrhosis, limiting specificity.
CA 15.3: It is primarily linked to breast cancer and may help in monitoring disease progression or recurrence. However, it has limited sensitivity for early detection and may be elevated in benign liver or inflammatory conditions.
CA 19.9: It is associated with pancreatic and other gastrointestinal cancer, but levels may also rise in benign conditions such as pancreatitis, cholestasis, or liver disease, and some individuals do not produce CA 19-9 due to Lewis antigen negativity.
Carcino embryonic Antigen (CEA): It is commonly linked with colorectal and other gastrointestinal cancers and is often used to monitor disease progression. However, it may be elevated in smokers and benign conditions such as inflammatory bowel disease, liver disease, or pancreatitis.
Thyroglobulin: It is produced by thyroid tissue and is mainly used for monitoring differentiated thyroid cancer after treatment. However, it is not suitable for primary screening and may be affected by thyroid disorders or anti-thyroglobulin antibodies.
CA 125: It may support evaluation and monitoring of ovarian cancer, but it may also be elevated in benign conditions such as endometriosis, menstruation, pelvic inflammatory disease, and pregnancy.
These parameters cannot be used as population screening tools because tbecause their levels may remain normal despite early malignancy and may increase in non-malignant conditions. These tests require imaging and histopathology to confirm cancer. When interpreted alongside clinical findings and imaging studies, the Cancer Marker Profile - Female provides valuable support for disease monitoring, treatment assessment, and informed cancer management in women.
The CBC (Complete Blood Count) test measures the number of red blood cells (RBCs), white blood cells (WBCs), and platelets. Each of these blood cells performs essential functions–RBCs carry oxygen from your lungs to the various body parts, WBCs help fight infections and other diseases, and platelets help your blood to clot. Therefore, determining their levels can provide significant health information. A CBC test also determines the hemoglobin level, a protein in RBC that carries oxygen from the lungs to the rest of your body. Evaluating all these components together can provide important information about your overall health.
Know more about CBC (Complete Blood Count)
Differential Leukocyte Count
- Differential Neutrophil Count
- Differential Lymphocyte Count
- Differential Monocyte Count
- Differential Eosinophil Count
- Differential Basophil Count
There are five types of WBCs: neutrophils, lymphocytes, monocytes, eosinophils, and basophils. A Differential Leukocyte Count test measures the percentage of each type of WBC in the blood. Leukocytes or WBCs are produced in the bone marrow and defend the body against infections and diseases. Each type of WBC plays a unique role to protect against infections and is present in different numbers.
This further contains
Red Blood Cell Count
The Red Blood Cell Count test measures the total number of red blood cells in your blood. RBCs are the most abundant cells in the blood with an average lifespan of 120 days. These cells are produced in the bone marrow and destroyed in the spleen or liver. Their primary function is to help carry oxygen from the lungs to different body parts. The normal range of RBC count can vary depending on age, gender, and the equipment and methods used for testing.
Platelet Count
The Platelet Count test measures the average number of platelets in the blood. Platelets are disk-shaped tiny cells originating from large cells known as megakaryocytes, which are found in the bone marrow. After the platelets are formed, they are released into the blood circulation. Their average life span is 7-10 days.
Platelets help stop the bleeding, whenever there is an injury or trauma to a tissue or blood vessel, by adhering and accumulating at the injury site and releasing chemical compounds that stimulate the gathering of more platelets. A loose platelet plug is formed at the site of injury and this process is known as primary hemostasis. These activated platelets support the coagulation pathway that involves a series of steps, including the sequential activation of clotting factors; this process is known as secondary hemostasis. After this step, there is a formation of fibrin strands that form a mesh incorporated into and around the platelet plug. This mesh strengthens and stabilizes the blood clot so that it remains in place until the injury heals. After healing, other factors come into play and break the clot down so that it gets removed. In case the platelets are not sufficient in number or not functioning properly, a stable clot might not form. These unstable clots can result in an increased risk of excessive bleeding.
Total Leukocyte Count
The Total Leukocyte Count test measures the numbers of all types of leukocytes, namely neutrophil, lymphocyte, monocyte, eosinophil, and basophil, in your blood. Leukocytes or WBCs are an essential part of our immune system. These cells are produced in the bone marrow and defend the body against infections and diseases. Each type of WBC plays a unique role to protect against infections and is present in different numbers.
Mean Corpuscular Volume
The Mean Corpuscular Volume test measures the average size of your red blood cells, which carry oxygen through your body. This test tells whether your RBCs are of average size and volume or whether they are bigger or smaller.
Mean Corpuscular Hemoglobin
An MCH test measures the average amount of hemoglobin in a single red blood cell (RBC). Hemoglobin is an iron-containing protein in RBCs, and its major function is to transport oxygen from the lungs to all body parts. This test provides information about how much oxygen is being delivered to the body by a certain number of RBCs.
Mean Corpuscular Hemoglobin Concentration
An MCHC test measures the average amount of hemoglobin in a given volume of RBCs. MCHC is calculated by dividing the amount of hemoglobin by hematocrit (volume of blood made up of RBCs) and then multiplying it by 100.
Absolute Leucocyte Count
- Absolute Lymphocyte Count (ALC)
- Absolute Neutrophil Count
- Absolute Basophil Count
- Absolute Monocyte Count
- Absolute Eosinophil Count
The Absolute Leucocyte Count test measures the total number of white blood cells (leucocytes) in the given volume of blood. It examines different types of white blood cells such as neutrophils, lymphocytes, monocytes, basophils and eosinophils. These cells tell about the status of the immune system and its ability to fight off infections and other conditions like inflammation, allergies, bone marrow disorders etc.
This further contains
Mean Platelet Volume
An MPV test measures the average size of the platelets in your blood. Platelets are disk-shaped tiny cells originating from large cells known as megakaryocytes, which are found in the bone marrow. After the platelets are formed, they are released into the blood circulation. Their average life span is 7-10 days.
Platelets help stop bleeding whenever there is an injury or trauma to a tissue or blood vessel by adhering and accumulating at the injury site, and by releasing chemical compounds that stimulate the gathering of more platelets. After these steps, a loose platelet plug is formed at the site of injury, and this process is known as primary hemostasis. These activated platelets support the coagulation pathway that involves a series of steps including the sequential activation of clotting factors; this process is known as secondary hemostasis. After this, there is a formation of fibrin strands that form a mesh incorporated into and around the platelet plug. This mesh strengthens and stabilizes the blood clot so that it remains in place until the injury heals. After healing, other factors come into play and break the clot down so that it gets removed. In case the platelets are not sufficient in number or are not functioning properly, a stable clot might not form. These unstable clots can result in an increased risk of excessive bleeding.
PDW
The PDW test reflects variability in platelet size, and is considered a marker of platelet function and activation (clot formation in case of an injury). This marker can give you additional information about your platelets and the cause of a high or low platelet count. Larger platelets are usually younger platelets that have been recently released from the bone marrow, while smaller platelets may be older and have been in circulation for a few days. Higher PDW values reflect a larger range of platelet size, which may result from increased activation, destruction and consumption of platelets.
RDW CV
The RDW CV test which is part of red cell indices, helps identify characteristics of red blood cells. RDW (red cell distribution width) measures the variations in the sizes of red blood cells, indicating how much they differ from each other in a blood sample. RDW is expressed as RDW-CV, a coefficient of variation. A higher RDW may suggest more variation in red cell sizes, while a lower RDW indicates more uniform red cell sizes.
The Carcino Embryonic Antigen Test test measures the level of a specific tumor marker called CEA In the blood, often associated with colon and rectal cancer. This biomarker is produced by certain tissues in the body, specifically gastrointestinal tissues, during fetal development. CEA levels drop to low or nonexistent levels after birth. Elevated levels of CEA in the blood may indicate the presence of certain cancers, particularly colorectal cancer. However, it's important to note that high CEA levels can also be linked to non-cancerous conditions.
For a comprehensive evaluation, it is advised to consider other diagnostic tests in conjunction with Carcino Embryonic Antigen Test test and consult a doctor for a proper understanding of the test results.
Know more about Carcino Embryonic Antigen Test





FAQs related to Cancer Marker Profile - Female in Koderma
- Fu Y, Li H. Assessing Clinical Significance of Serum CA15-3 and Carcinoembryonic Antigen (CEA) Levels in Breast Cancer Patients: A Meta-Analysis. Med Sci Monit. 2016 Sep 6;22:3154-62. [Accessed 27 Jan 2026].
- Kankanala VL, Zubair M, Mukkamalla SKR. Carcinoembryonic Antigen. [Updated 2024 Dec 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from:
- Adigun OO, Yarrarapu SNS, Zubair M, et al. Alpha-Fetoprotein Analysis. [Updated 2024 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from:
- Zhang GM, Bai SM, Zhang GM, Ma XB. Reference intervals of carbohydrate antigen 19-9 in the apparently healthy adult population. J Clin Lab Anal. 2018 Jun;32(5):e22380. [Accessed 27 Jan 2026].
- Barlow M, Down L, Mounce LTA, Funston G, Merriel SWD, Watson J, Abel G, Kirkland L, Martins T, Bailey SER. The diagnostic performance of CA-125 for the detection of ovarian cancer in women from different ethnic groups: a cohort study of English primary care data. J Ovarian Res. 2024 Aug 26;17(1):173. [Accessed 27 Jan 2026].
- Indrasena BS. Use of thyroglobulin as a tumour marker. World J Biol Chem. 2017 Feb 26;8(1):81-85. [Accessed 27 Jan 2026].
Other tests
- Good Health Gold Package with Smart Report in Koderma
- CBC (Complete Blood Count) in Koderma
- KFT with Electrolytes (Kidney Function Test with Electrolytes) in Koderma
- Urine R/M (Urine Routine & Microscopy) in Koderma
- Histopathology: Second Opinion(6-15 Blocks) in Koderma
- Health Care Package DIABETES ADVANCE in Koderma
- Health Care CARDIAC MARKERS in Koderma
- Health Care Package Women in Koderma
- Histopathology (Radical Specimen) in Koderma
- Health Care Package COMPREHENSIVE Advance in Koderma
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar) Test
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin) Test
- PPBS (Postprandial Blood Sugar) Test
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive Test
- ESR (Erythrocyte Sedimentation Rate) Test
- Uric Acid, Serum Test
- Vitamin B12 Test
- CRP (C-Reactive Protein), Quantitative Test
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes Test
- Serum Calcium Test
- Serum Creatinine Test
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total Test
- Hb (Hemoglobin) Test
- Complete Hemogram (CBC & ESR)





